Aviva plc (OTCMKTS:AVVIY – Get Free Report) was the target of a significant decline in short interest in the month of January. As of January 15th, there was short interest totalling 14,700 shares, a decline of 75.8% from the December 31st total of 60,800 shares. Based on an average trading volume of 77,800 shares, the days-to-cover ratio is presently 0.2 days.
Aviva Stock Up 0.3 %
Aviva stock traded up $0.04 during trading hours on Thursday, hitting $12.83. The company had a trading volume of 11,176 shares, compared to its average volume of 31,200. The firm’s fifty day moving average is $12.17 and its 200-day moving average is $12.56. Aviva has a fifty-two week low of $10.50 and a fifty-two week high of $13.58.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently issued reports on AVVIY shares. Hsbc Global Res upgraded shares of Aviva from a “hold” rating to a “strong-buy” rating in a report on Friday, November 15th. Royal Bank of Canada upgraded shares of Aviva to a “moderate buy” rating in a report on Thursday, October 3rd. Keefe, Bruyette & Woods upgraded shares of Aviva from a “hold” rating to a “moderate buy” rating in a research note on Wednesday, November 27th. Finally, BNP Paribas upgraded shares of Aviva from a “strong sell” rating to a “hold” rating in a research note on Thursday, December 5th. One equities research analyst has rated the stock with a hold rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Buy”.
About Aviva
Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products.
Read More
- Five stocks we like better than Aviva
- Using the MarketBeat Stock Split Calculator
- How Value Investors Find Undervalued Stocks and Build Wealth
- What to Know About Investing in Penny Stocks
- Is Tonix Pharmaceuticals the Next Biotech Breakout?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- DeepSeek Dip: Is the Nuclear Energy Sell-Off a Buying Opportunity
Receive News & Ratings for Aviva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aviva and related companies with MarketBeat.com's FREE daily email newsletter.